Guardant Health
GH
#985
Rank
C$33.54 B
Marketcap
C$249.94
Share price
-3.51%
Change (1 day)
80.32%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2026 (TTM): -C$0.64 Billion

According to Guardant Health 's latest financial reports the company's current earnings are C$1.18 Billion. In 2025 the company made an earning of -C$0.59 Billion, an increase over its 2024 earnings that were of -C$0.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.64 Billion8.44%
2025 -C$0.59 Billion-4.03%
2024 -C$0.61 Billion-9.12%
2023 -C$0.67 Billion-26.73%
2022 -C$0.92 Billion69.96%
2021 -C$0.54 Billion56.35%
2020 -C$0.35 Billion252.69%
2019 -C$97.47 Million-17.22%
2018 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-C$12.52 Million-98.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-C$0.36 Billion-44.40%๐Ÿ‡บ๐Ÿ‡ธ USA